Clinical Trial

A Multicenter Study of CAR-T Cells in Primary Ph+All

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
A Multicenter Study of CD19 CAR-T Cells in the Treatment of Adult Patients With Primary Ph Chromosome Positive Acute Lymphoblastic Leukemia
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-18.
Trial Details
NCT Number NCT07252336
Lead Sponsor Zhejiang University
Collaborators: Yake Biotechnology Ltd.
Conditions ALL
Enrollment 50 participants
Start Date 2025-11-30
Primary Completion 2027-11-30 (estimated)
Study Completion 2028-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-04